• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Acelyrin

merge MA railway train tracks path together
Biotech

Activist investor fails to derail Alumis' Acelyrin merger

Acelyrin’s shareholders have decided to power ahead with the merger despite the best efforts of an activist investor to sink the deal.
James Waldron May 14, 2025 7:45am
Graphic image of a red thumbs down against a blue background

Investor pressures Acelyrin to exit Alumis merger and liquidate

Apr 30, 2025 10:30am
poison pill toxic poison

Pliant, Acelyrin take ‘poison pills’ as Concentra buyout looms

Mar 14, 2025 10:01am
blocks with checks and crosses

Acelyrin turns down surprise Concentra buyout offer

Mar 4, 2025 10:26am
illustration of two arrows going in opposite directions

Concentra curveball intrudes on Acelyrin-Alumis merger

Feb 21, 2025 7:35am
MA strategy deal block push come together form

Acelyrin to be absorbed into Alumis in all-stock merger

Feb 7, 2025 5:35am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings